Precise spatial structure impacts antimicrobial susceptibility of S. aureus in polymicrobial wound infections

Proc Natl Acad Sci U S A. 2022 Dec 20;119(51):e2212340119. doi: 10.1073/pnas.2212340119. Epub 2022 Dec 15.

Abstract

A hallmark of microbial ecology is that interactions between members of a community shape community function. This includes microbial communities in human infections, such as chronic wounds, where interactions can result in more severe diseases. Staphylococcus aureus is the most common organism isolated from human chronic wound infections and has been shown to have both cooperative and competitive interactions with Pseudomonas aeruginosa. Still, despite considerable study, most interactions between these microbes have been characterized using in vitro well-mixed systems, which do not recapitulate the infection environment. Here, we characterized interactions between S. aureus and P. aeruginosa in chronic murine wounds, focusing on the role that both macro- and micro-scale spatial structures play in disease. We discovered that S. aureus and P. aeruginosa coexist at high cell densities in murine wounds. High-resolution imaging revealed that these microbes establish a patchy distribution, only occupying 5 to 25% of the wound volume. Using a quantitative framework, we identified a precise spatial structure at both the macro (mm)- and micro (µm)-scales, which was largely mediated by P. aeruginosa production of the antimicrobial 2-heptyl-4-hydroxyquinoline N-oxide, while the antimicrobial pyocyanin had no impact. Finally, we discovered that this precise spatial structure enhances S. aureus tolerance to aminoglycoside antibiotics but not vancomycin. Our results provide mechanistic insights into the biogeography of S. aureus and P. aeruginosa coinfected wounds and implicate spatial structure as a key determinant of antimicrobial tolerance in wound infections.

Keywords: Pseudomonas aeruginosa; Staphylococcus aureus; antibiotic resistance; biogeography; chronic wounds.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Coinfection*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Mice
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus
  • Wound Infection* / drug therapy

Substances

  • Anti-Bacterial Agents